Global

medicine

Global Regenerative Medicine Market Research Report 2020

DUBLIN, Dec. 4, 2020 /PRNewswire/ — The “Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

The Global Regenerative Medicine Market is Projected to Reach USD 17.9 Billion by 2025 from USD 8.5 Billion in 2020, at a CAGR of 15.9% during the Forecast Period.

Market growth is driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products. However, the high cost of cell and gene therapies and ethical concerns related to the use of embryonic stem cells in research and development are expected to restrain the growth of this market during the forecast period.

The cell therapies segment accounted for the highest growth rate in the regenerative medicine market, by product, during the forecast period

Based on products, the regenerative medicine market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The cell therapies segment accounted for the highest growth rate in the regenerative medicine market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.

Oncology segment accounted for highest CAGR

Based on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Chronic Diseases, Genetic Disorders, and Cancer
5.2.1.2 Rising Investments in Regenerative Medicine Research
5.2.1.3 Growing Pipeline of Regenerative Medicine Products
5.2.2 Restraints
5.2.2.1 Ethical Concerns Related to the Use of Embryonic Stem Cells in Research & Development
5.2.2.2 High Cost of Cell and Gene Therapies
5.2.3 Opportunities
5.2.3.1 Implementation of the 21st Century Cures Act
5.2.3.2 Rising Demand for Organ Transplantations
5.3 Impact of the COVID-19 Pandemic on the Regenerative Medicine Market

6 Regenerative Medicine Market, by Product
6.1 Introduction
6.2 Tissue-Engineered Products
6.2.1 Rising Prevalence of Chronic Wounds to Drive the Market Growth
6.3 Cell Therapies
6.3.1 Autologous Therapies
6.3.1.1 Autologous Therapies Segment to Register the Highest Growth in the Cell Therapies Market
6.3.2 Allogeneic Therapies
6.3.2.1 Rising Incidence of Chronic Conditions to Drive the Market Growth
6.4 Gene Therapies
6.4.1 Growing Number of Cancer Cases to Drive Market Growth
6.5 Progenitor & Stem Cell Therapies
6.5.1 Growing Product Pipeline to Support the Growth of this Segment

7

Read More
medicine

Global Ophthalmic Medicine Market 2020 Size, Market Share, Key Players, Segmentation Development and Forecast by 2025

The MarketWatch News Department was not involved in the creation of this content.

Dec 02, 2020 (CDN Newswire via Comtex) —
The report entitled Global Ophthalmic Medicine Market 2020 by Manufacturers, Type and Application, Forecast to 2025 compiled by MarketQuest.biz presents a new market research analysis that offers a detailed evaluation of the business vertical and a brief overview of the industry segments. The report includes an elemental introduction to the industry, market overview, scope, and product specification. The report aims to target the major images related to market growth, major types, and various end users applicable, regional analysis, productivity structure, current, and future market situation. The report provides a determined perception of the popular market situation that also covers market size in terms of value and volume. Important segment classification of this market includes global Ophthalmic Medicine market-leading players, major geographical regions, product types, and applications.

The report describes the growth of the market such as manufacturers, market size, types, applications, and regions. The report highlights key factors driving and restraining market growth. The research portrays previous and forecasts information in the form of graphical representation. Factors that are encouraging the growth of a specific type of product category and factors that are motivating the status of the market are further included in this report. A comprehensive study of the market is done to recognize the several applications of the features of products and usage.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

DOWNLOAD FREE SAMPLE REPORT:https://www.marketquest.biz/sample-request/20234

The major players who are leading the market throughout the globe are: Novaliq, Mentholatum, Chengdu Kanghong Pharmaceutical Group, Shenyang Xingqi Pharmaceutical Co.,Ltd., Alcon NV, Zhejiang Shapuaisi Pharmaceutical, Bausch Health, Santen Pharmaceutica

Moreover, the report concentrates on global higher leading business players with their details such as company profiles, product picture and specifications, sales, market share, and association information. Additionally, developing strategies and programs are addressed as well as manufacturing methods and cost formations are included. The research contains an analysis of the strategies of major competitors. Elements such as production capacity, price, demand, supply chain/logistics, profit/loss, material parameters/specifications, and the growth factor have been reviewed in the report.

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including: Anti-fatigue and Dryness, Cataract, Anti-infective

On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share, and growth rate of each type, primarily split into: Eye Drops, Eye Ointment, Gelling Agent, Tablet, Injection

Keeping the regional landscape of the global Ophthalmic Medicine market in mind, this industry is segmented into: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast

Read More
medicine

Sports Medicine Market Analysis by Applications, End-Users, Top Companies, Future Growth Opportunities, Product Type, Global Forecast To 2020

The MarketWatch News Department was not involved in the creation of this content.

Japan, Japan, Wed, 02 Dec 2020 14:20:31 / Comserve Inc. / — Over the years, the sports medicine market has witnessed various technological advancements made to ensure and provide better recovery and rehabilitative measures for injuries caused during sports or physical activities.

The sports medicine market comprises products and devices used by professional or non-professional athletes or sportspersons to prevent and protect themselves from injuries as well as devices that enhance performance. The sports medicine products play an important role in the rehabilitation, recovery, protection, endurance, and monitoring of athletes while playing sports. Over the years, the sports medicine market has witnessed various technological advancements made to ensure and provide better recovery and rehabilitative measures for injuries caused during sports or physical activities.

These advancements have led to the development of new products and therapies to treat sports injuries. Various market players are focusing on the introduction of newer products and treatment options for sports injuries. A number of key players are competing to secure larger shares of the market by launching new products. Arthrex, Inc. (U.S.), Smith & Nephew PLC (U.K.), DePuy Synthes Companies (U.S.), Stryker Corporation (U.S.), and CONMED Corporation (U.S.) are the top five players of this market

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-61031

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

In 2015, the body reconstruction & repair products segment is expected to account for the largest share of the global sports medicine market, by product, while the knee injuries segment is expected to account for the largest share of the sports medicine market, by application.

In 2015, North America is expected to account for the largest share of the global sports medicine market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). In the coming years, the sports medicine market is expected to witness the highest growth rate in the Asia-Pacific region, with emphasis on India, China, and Japan. The entry of international players, increasing government initiatives, and rising awareness regarding sports medicine in emerging nations like India and China are expected to drive the market in these regions.

The sports medicine market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various growth strategies (agreements, partnerships, joint ventures, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market

Read More
medicine

Nuclear Medicine Market Research Report by Product, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19 – Press Release

New York, Dec. 01, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Nuclear Medicine Market Research Report by Product, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19” – https://www.reportlinker.com/p05993422/?utm_source=GNW

The Global Nuclear Medicine Market is expected to grow from USD 3,812.67 Million in 2019 to USD 5,701.38 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.93%.

Market Segmentation & Coverage:
This research report categorizes the Nuclear Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Nuclear Medicine Market studied across Diagnostic Products and Therapeutic Products. The Diagnostic Products further studied across PET and SPECT. The Therapeutic Products further studied across Alpha Emitters, Beta Emitters, and Brachytherapy.

Based on Application, the Nuclear Medicine Market studied across Bone Metastasis, Cardiology, Endocrine Tumor, Lymphoma, Oncology, and Thyroid.

Based on Geography, the Nuclear Medicine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Nuclear Medicine Market including Australian Nuclear Science & Technology Organization (ANSTO), Bracco Imaging S.p.A, Curium Pharma, Eckert & Ziegler, Eczacibasi-Monrol, GE Healthcare, Jubilant Pharma. LLC, Lantheus Medical Imaging, Inc., Mallinckrodt, Nordion (Canada) Inc., NTP Radioisotopes SOC Ltd., and The Institute for Radioelements (IRE – IRE ELiT).

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Nuclear Medicine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces,

Read More
medicine

Global Ayurvedic Medicine Market Size by Regional Industry Growth, Statistics & Forecast by 2025

The MarketWatch News Department was not involved in the creation of this content.

Nov 26, 2020 (Market Insight Reports) —
Selbyville, Delaware, MarketStudyReport.com offers report on Global Ayurvedic Medicine Market that evaluates industry growth trends through historical data and estimates prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2020 – 2025.

The global Ayurvedic Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.4% in the forecast period of 2020 to 2025 and will expected to reach 7331.5 million by 2025, from 4754.3 million in 2019.

The Ayurvedic Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Request a sample copy of this report at:

https://www.marketstudyreport.com/request-a-sample/2468922/?utm_source=Marketwatch.com&utm_medium=SK

Main Objectives of this Global Ayurvedic Medicine Marketstudy:

To provide detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the Global Ayurvedic Medicine Market.

To strategically analyze the Micro markets with respect to individual growth trends, Prospects, and Contributions to the total market.

To analyze opportunities in the overall Global Ayurvedic Medicine Market for stakeholders by identifying the high growth segments.

To describe and forecast the overall Global Ayurvedic Medicine Market, in terms of value, segmented based on type, and application.

To forecast the market size for various segments, by key region.

The Global Ayurvedic Medicine Market spans across five major geographies: North America, Latin America, Europe, Asia-Pacific and the Middle East and Africa.

To analyze opportunities in the overall Global Ayurvedic Medicine Market for stakeholders by identifying the high growth segments.

To profile key players and analyze their Market ranking in terms of revenues and core competencies and provide details of the competitive landscape for the Global Ayurvedic Medicine Market leaders.

To analyze growth strategies such as Contracts, Mergers and Acquisitions, Product launches and Developments, and Research and Development in the overall Global Ayurvedic Medicine Market.

Segmentation of Global Ayurvedic Medicine Market:

Ayurvedic Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Ayurvedic Medicine market has been segmented into:

Health Care

Oral Care

Hair Care

Skin Care

Others

By Application, Ayurvedic Medicine has been segmented into:

Women

Men

Kids

key Companies covered:

Patanjali Ayurved Limited

Vicco Laboratories

Himalaya Drug

Dabur

Shahnaz Husain Group

Emami Group

Charak Pharma

Baidyanalh

Maharishi Ayurveda

Amrutanjan Healthcare

Botique

Natreon

Herbal Hills

Basic Ayurveda

Main reasons for the purchase:

To obtain insightful analysis of the Global Ayurvedic Medicine Market and a comprehensive understanding of

Read More
medicine

Regenerative Medicine Market 2020 Global Trends Evaluation, Geographical Segmentation, and Investment Opportunities till 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 25, 2020 (AmericaNewsHour) —
The Regenerative Medicine Market report provides an in-depth analysis of the Healthcare & Pharmaceuticals during the forecast period 2017-2026 which consists of the industry overview including the market size, volume, growth rate and recent trends and developments in the market based on historical and current data. The report covers detailed information about the key players, market segments, growth drivers and restraints in the industry. The report delivers an insight into the Regenerative Medicine Market which allows our clients to make informed decisions regarding the growth of their businesses.

The Regenerative Medicine Market is anticipated to reach over USD 79.23 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the cell therapy dominated the global Regenerative Medicine market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue in 2017.
Regenerative medicine is a branch of medicine that regrows, and repairs the damaged cells in the human body. These medicines include the use of stem cells, tissue engineering, that further helps in developing new organ that function smoothly. These medicines have the caliber of developing an entire organ as these cells are multipotent. The cells are majorly isolated from bone marrow, and umbilical cord blood.

Download free Sample of This Strategic Report:- https://www.kennethresearch.com/sample-request-10070801

The regenerative medicine market is primarily driven by the increasing number of individuals suffering from cancer, rising need to monitor and treating these chronic diseases in the limited time. Furthermore, stringent government policies, proper reimbursement policies, and increasing government healthcare expenditure for developing healthcare infrastructure to also boost the market growth in coming years. Also, rising number of organ transplantation, and increasing number of products in pipeline that are waiting for approval create major opportunity for the regenerative medicines in the coming years. However, some of the ethical and religious concerns for the use of stem cells, and lack of proper regulatory for the approval of various drugs would impede the market growth during the forecast period.

North America generated the highest revenue in the Regenerative Medicine market in 2017, and is expected to be the leading region globally during the forecast period. Increasing number of patients suffering from chronic diseases, improved healthcare infrastructure and health facilities, accessibility of healthcare facilities, are the primary factors driving the market growth in this region. While, Asia Pacific to be the fastest growing region in the coming years. The growth in this region is majorly attributed to the developing healthcare infrastructure of the countries like India, & China, and rising awareness for the use of regenerative medicines as an effective treatment option for chronic diseases.

The key players operating in the Regenerative Medicine market include Organogenesis Inc., Vericel Corporation, Osiris Therapeutics, Inc., Stryker Corporation, and NuVasive, Inc., Medtronic Plc., Acelity, Cook Biotech Inc., Integra LifeSciences, and C.R. Bard. These companies launch new products and collaborate with other market leaders

Read More
medicine

Digital Medicine Market Size Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 24, 2020 (Market Insight Reports) —
Selbyville, Delaware. Market Study Report LLC: A comprehensive research study on Digital Medicine market added by Market Study Report LLC provides insights into the market size and growth trends of this industry over the forecast timeline. The study evaluates key aspects of Digital Medicine market in terms of the demand landscape, driving factors and growth strategies adopted by market players.

This report presents a comprehensive overview, market shares, and growth opportunities of Digital Medicine market by product type, application, key manufacturers and key regions and countries.

Digital medicine technology is an innovative technological technique that has bridged the gap among the healthcare and digital technology. Due to advancement in health care, scientific medicine is pioneered the concept of digital medicine that aims in supporting individualized medicine by recognizing the biology of a patient via a wireless sensor technology and other technologies related to mobile health. Digital medicine is more privileged than recent medical practice as it is more effective, precise, feasible and well distributed technology. Growing healthcare expenditure, high penetration of smartphones, along with high percentage of population with chronic diseases are the few factor responsible for high CAGR of the market over the forecast period.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2495936/?utm_source=Marketwatchtm.com/&utm_medium=AK

Major market player included in this report are:

2Morrow

Ginger

Akili Interactive

Livongo

AliveCor

WellDoc

Mocacare

Proteus Digital Health Voluntis

Omada Health

Digital Medicine Market outlook: Apart from exploring into the various segments, the report clustered on key Digital Medicine Market trends and sectors that are either driving or averting the growth of the Digital Medicine industry. Growth policies and plans are mentioned likewise as producing processes and cost structures also are analyzed. The Digital Medicine Market industry development trends are studied through both secondary and primary sources. Finally, the feasibility of the latest investment comes is assessed and overall analysis conclusions offered in Digital Medicine market analysis report.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Mobile Health

EMR/EHR

Telehealth

Wireless Health

By Application:

Diabetes

Mental Health

Heart Diseases

Others

Research objectives

To study and analyze the global Digital Medicine market size by key regions/countries, type and application, history data from 2016 to 2017, and forecast to 2026.

To understand the

Read More
fitness

Global fitness app market size valuation to reach USD 15.96 billion by 2026

Selbyville, Delaware, Nov. 24, 2020 (GLOBE NEWSWIRE) — As per reliable estimates, worldwide fitness app market size is predicted to reach USD 15.96 billion mark by 2026. Rising concerns associated with unhealthy habits, evolving consumer lifestyle, and growing obese population are some of the key factors propelling the market expansion.

The study elaborates on several market segmentations including app type, device type, OS platform type, and regional outlook. Additionally, the document conducts a thorough SWOT analysis of various companies operating in this business sphere.

The research report also analyzes the impact of COVID-19 outbreak on industry expansion graph and valuation in the ensuing years, further allowing for advanced decision-making during investment assessment.

Request Sample copy of this Report @https://www.marketstudyreport.com/request-a-sample/1695317/

The surge in obese population coupled with rising adoption of sedentary lifestyle have resulted in increased pervasiveness of diseases such as hypertension and diabetes. In addition to this, rising per capita income along with increasing awareness pertaining to health and nutrition are stimulating the overall industry outlook.

According to industry analysts, the number of gym and health club memberships has significantly increased in the recent past. Additionally, rising smartphone penetration, widespread adoption of mobile devices, and easy accessibility to high-speed internet are positively impacting the remuneration scale of global fitness app market.

Availability of numerous types of fitness apps such as Sweat: Kayla Itsines Fitness and Runstatic coupled with high concentration of companies are also facilitating the business scenario. In 2015 for instance, Adidas acquired the Austrian company Runstatic in order to improve its overall market share. Thus, focus among major companies towards expanding their product portfolio through innovative launches and strategic collaborations are aiding the expansion of global fitness app market.

Highlighting the regional outlook

Global fitness app industry is bifurcated into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. According to authentic estimations, North America is expected to capture majority market share by the year 2026.

Growing population and surging disposable income are favoring the regional market outlook. Moreover, widespread adoption of sedentary lifestyle and rising health concerns have augmented the demand for fitness apps, which in turn is positively swaying the business dynamics in North America.

Meanwhile, Asia-Pacific fitness app market is set to record the highest CAGR through 2026. Factors such as growing purchasing power, rising health cognizance, high concentration of fitness centers, and increasing smartphone penetration have allowed Asia-Pacific to emerge as a major revenue generator for worldwide fitness app market.

To access a sample copy or view this report in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/fitness-app-market-share-size-trends-industry-analysis-report-by-app-type-fitness-and-activity-tracking-diet-and-nutrition-by-device-type-smartphones-tablets-wearable-devices-by-gender-by-os-platform-by-region-segment-forecast-2018-2026

Global Fitness App Market by App Type (Revenue, USD Billion, 2015-2026)

  • Medication Adherence
  • Lifestyle Management
  • Nutrition & Diet
  • Disease Management
  • Workout & Exercise Apps

Global Fitness App Market by Device Terrain (Revenue, USD Billion, 2015-2026)

  • Wearable Devices
  • Tablets
  • Smartphones

Global Fitness App Market by OS Platform (Revenue, USD Billion, 2015-2026)

Global Fitness App Market Regional Outlook (Revenue, USD Billion, 2015-2026)

North America

Europe

  • Netherlands
  • Russia
  • Belgium
  • Spain
Read More
medicine

Global Regenerative Medicine Market 2020-2025: Opportunities with the Implementation of the 21st Century Cures Act

Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) — The “Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

The Global Regenerative Medicine Market is Projected to Reach USD 17.9 Billion by 2025 from USD 8.5 Billion in 2020, at a CAGR of 15.9% during the Forecast Period.

Market growth is driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products. However, the high cost of cell and gene therapies and ethical concerns related to the use of embryonic stem cells in research and development are expected to restrain the growth of this market during the forecast period.

The cell therapies segment accounted for the highest growth rate in the regenerative medicine market, by product, during the forecast period

Based on products, the regenerative medicine market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The cell therapies segment accounted for the highest growth rate in the regenerative medicine market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.

Oncology segment accounted for highest CAGR

Based on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.

Europe: The fastest-growing region regenerative medicine market

The global regenerative medicine market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. The North America region is projected to grow at the highest CAGR during the forecast period in 2019. The growth in the North American regenerative medicine market can be attributed to rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases.

Market Dynamics

Drivers

  • Rising Prevalence of Chronic Diseases, Genetic Disorders, and Cancer
  • Rising Investments in Regenerative Medicine Research
  • Growing Pipeline of Regenerative Medicine Products

Restraints

  • Ethical Concerns Related to the Use of Embryonic Stem Cells in Research & Development
  • High Cost of Cell and Gene Therapies

Opportunities

  • Implementation of the 21st Century Cures Act
  • Rising Demand for Organ Transplantations

Impact of the COVID-19 Pandemic on the Regenerative Medicine Market

Companies Mentioned

  • 3M Group
  • Allergan
  • Amgen, Inc.
  • Anterogen Co., Ltd.
  • APAC Biotech
  • Aspect Biosystems
  • Bluebird Bio
  • Corestem, Inc.
  • Integra Lifesciences Holdings Corporation
  • Kite Pharma
Read More
medicine

Global Regenerative Medicine Market 2020-2025: Opportunities with the Implementation of the 21st Century Cures Act – Press Release

Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) — The “Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

The Global Regenerative Medicine Market is Projected to Reach USD 17.9 Billion by 2025 from USD 8.5 Billion in 2020, at a CAGR of 15.9% during the Forecast Period.

Market growth is driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products. However, the high cost of cell and gene therapies and ethical concerns related to the use of embryonic stem cells in research and development are expected to restrain the growth of this market during the forecast period.

The cell therapies segment accounted for the highest growth rate in the regenerative medicine market, by product, during the forecast period

Based on products, the regenerative medicine market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The cell therapies segment accounted for the highest growth rate in the regenerative medicine market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.

Oncology segment accounted for highest CAGR

Based on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.

Europe: The fastest-growing region regenerative medicine market

The global regenerative medicine market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. The North America region is projected to grow at the highest CAGR during the forecast period in 2019. The growth in the North American regenerative medicine market can be attributed to rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases.

Market Dynamics

Drivers

  • Rising Prevalence of Chronic Diseases, Genetic Disorders, and Cancer
  • Rising Investments in Regenerative Medicine Research
  • Growing Pipeline of Regenerative Medicine Products

Restraints

  • Ethical Concerns Related to the Use of Embryonic Stem Cells in Research & Development
  • High Cost of Cell and Gene Therapies

Opportunities

  • Implementation of the 21st Century Cures Act
  • Rising Demand for Organ Transplantations

Impact of the COVID-19 Pandemic on the Regenerative Medicine Market

Companies Mentioned

  • 3M Group
  • Allergan
  • Amgen, Inc.
  • Anterogen Co., Ltd.
  • APAC Biotech
  • Aspect Biosystems
  • Bluebird Bio
  • Corestem, Inc.
  • Integra Lifesciences Holdings Corporation
  • Kite Pharma
  • Medipost
Read More